Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.

Kabbage M, Trimeche M, Ben Nasr H, Hammann P, Kuhn L, Hamrita B, Chaieb A, Chouchane L, Chahed K.

Tumour Biol. 2012 Dec;33(6):2279-88. doi: 10.1007/s13277-012-0490-4. Epub 2012 Sep 13.

PMID:
22972503
2.

Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.

Kabbage M, Trimeche M, Bergaoui S, Hammann P, Kuhn L, Hamrita B, ben Nasr H, Chaieb A, Chouchane L, Chahed K.

Tumour Biol. 2013 Apr;34(2):1177-88. doi: 10.1007/s13277-013-0661-y. Epub 2013 Jan 22.

PMID:
23334957
3.

Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study.

Kabbage M, Trimeche M, Ben Nasr H, Hammann P, Kuhn L, Hamrita B, Chahed K.

Tumour Biol. 2013 Dec;34(6):3593-602. doi: 10.1007/s13277-013-0939-0. Epub 2013 Jun 28.

PMID:
23812729
4.

High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.

Somiari RI, Sullivan A, Russell S, Somiari S, Hu H, Jordan R, George A, Katenhusen R, Buchowiecka A, Arciero C, Brzeski H, Hooke J, Shriver C.

Proteomics. 2003 Oct;3(10):1863-73.

PMID:
14625848
5.

AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.

Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK.

Ann Diagn Pathol. 2008 Feb;12(1):33-40. doi: 10.1016/j.anndiagpath.2007.02.004. Epub 2007 Oct 24.

PMID:
18164413
6.

Armc8 expression was elevated during atypia-to-carcinoma progression and associated with cancer development of breast carcinoma.

Fan C, Zhao Y, Mao X, Miao Y, Lin X, Jiang G, Zhang X, Han Q, Luan L, Wang E.

Tumour Biol. 2014 Nov;35(11):11337-43. doi: 10.1007/s13277-014-2473-0. Epub 2014 Aug 14.

PMID:
25119601
7.

ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.

Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK.

Urol Oncol. 2013 Oct;31(7):1367-77. doi: 10.1016/j.urolonc.2012.01.015. Epub 2012 Mar 13.

PMID:
22417627
8.

CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.

Pathol Res Pract. 2006;202(8):569-76. Epub 2006 Jul 7.

PMID:
16828238
9.

Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.

Xie F, Wang Q, Chen Y, Gu Y, Mao H, Zeng W, Zhang X.

Pathol Res Pract. 2010 Nov 15;206(11):735-9. doi: 10.1016/j.prp.2010.05.016. Epub 2010 Jul 15.

PMID:
20634005
10.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
11.

Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.

Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Mizutoh A, Moriya T, Sonoo H.

Breast Cancer. 2015 May;22(3):292-9. doi: 10.1007/s12282-013-0478-y. Epub 2013 Jun 8.

PMID:
23749689
12.

Positive immunohistochemical expression of bcl-2 in hormone-independent breast carcinomas is associated with a greater lymph node involvement and poor outcome.

Ruibal Á, Aguiar P, Del Río MC, Menéndez P, Arias JI, Herranz M.

Med Oncol. 2014 Aug;31(8):105. doi: 10.1007/s12032-014-0105-6. Epub 2014 Jul 10.

PMID:
25008065
13.

Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.

Buta M, Džodić R, Đurišić I, Marković I, Vujasinović T, Markićević M, Nikolić-Vukosavljević D.

Tumour Biol. 2015 Sep;36(10):8193-200. doi: 10.1007/s13277-015-3573-1. Epub 2015 May 21.

PMID:
25994573
14.

alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.

Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE.

Cancer. 2004 Jun 15;100(12):2543-8.

15.

Anti-chaperone betaA3/A1(102-117) peptide interacting sites in human alphaB-crystallin.

Rao G, Santhoshkumar P, Sharma KK.

Mol Vis. 2008 Mar 26;14:666-74.

16.

Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.

Ravikumar G, Ananthamurthy A.

J Cancer Res Ther. 2014 Jul-Sep;10(3):671-5. doi: 10.4103/0973-1482.138135.

17.
18.

Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.

Kim MS, Lee HW, Jun SY, Lee EH.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):8842-56. eCollection 2015.

19.

Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.

Taliano RJ, Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E.

Hum Pathol. 2013 Dec;44(12):2743-50. doi: 10.1016/j.humpath.2013.07.021.

20.

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA.

Cancer. 2002 Apr 1;94(7):1910-6.

Supplemental Content

Support Center